P

Peijia Medical Ltd
HKEX:9996

Watchlist Manager
Peijia Medical Ltd
HKEX:9996
Watchlist
Price: 3.77 HKD 0.8% Market Closed
Market Cap: 2.5B HKD
Have any thoughts about
Peijia Medical Ltd?
Write Note

Peijia Medical Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Peijia Medical Ltd
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
P
Peijia Medical Ltd
HKEX:9996
Cash from Financing Activities
ÂĄ85.1m
CAGR 3-Years
-67%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Cash from Financing Activities
-ÂĄ246.4m
CAGR 3-Years
-34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Cash from Financing Activities
-ÂĄ1.9B
CAGR 3-Years
N/A
CAGR 5-Years
-61%
CAGR 10-Years
N/A
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Cash from Financing Activities
-ÂĄ12B
CAGR 3-Years
-38%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Cash from Financing Activities
-ÂĄ840.6m
CAGR 3-Years
N/A
CAGR 5-Years
-34%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Cash from Financing Activities
-ÂĄ662.2m
CAGR 3-Years
20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Peijia Medical Ltd
Glance View

Market Cap
2.6B HKD
Industry
Health Care

Peijia Medical Ltd. engages in the manufacture and sale of medical devices. The company is headquartered in Suzhou, Jiangsu. The company went IPO on 2020-05-15. Through its subsidiaries, the Company operates two segments. Transcatheter Valve Therapeutic Business segment is mainly engaged in the development of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is engaged in the research and development of neurointerventional procedural medical devices. The firm's main products under development include TaurusOne, TaurusElite, TaurusNXT and others. The firm operates its businesses primarily in domestic market.

Intrinsic Value
5.13 HKD
Undervaluation 27%
Intrinsic Value
Price
P

See Also

What is Peijia Medical Ltd's Cash from Financing Activities?
Cash from Financing Activities
85.1m CNY

Based on the financial report for Dec 31, 2023, Peijia Medical Ltd's Cash from Financing Activities amounts to 85.1m CNY.

What is Peijia Medical Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-4%

Over the last year, the Cash from Financing Activities growth was -28%. The average annual Cash from Financing Activities growth rates for Peijia Medical Ltd have been -67% over the past three years , -4% over the past five years .

Back to Top